Rebecca Ivatts
For fine art and commissions click here


After graduating in Modern Languages from Oxford University, Rebecca studied Objective Life Drawing and Painting at the Slade School of Art and Anatomy at the Princes Drawing School. Subsequently, she took classes in expressive life drawing with two tutors from the Royal College of Art. After living in Madrid for four years – where she gained a diploma in Painting Processes and Techniques at San Fernando Arts Academy - Rebecca has returned to London where she has her studio. Rebecca has exhibited her work in London, Madrid, Hungary, Athens and Ireland.

  • Rebecca Ivatts
  • Rebecca Ivatts
  • Rebecca’s art had always focused on the nude, but the antenatal scans of her first child compelled her to take her paintbrush ‘inside’ for the first time…

    With initial guidance from a London radiographer, brain imaging came as an epiphany – a springboard for the imagination, for finding the ‘out there’ through the ‘in here’. An angiogram took on the totemic symmetry of a tribal mask, a major stroke looked like an incredible opening up to the world. Rebecca peered into white and grey matter and saw dense ‘gardens’ inhabited by bodies, ghosts, constellations…

    Rebecca is artist-in-residence 2020/21 at the Wohl Cellular Imaging Centre at the Maurice Wohl Clinical Neuroscience Institute at King's College London. Works from this 'THROUGH THE LENS' series will go on show at King's Festival 2021.

    Rebecca has collaborated with neuroscientist and Parkinson’s specialist Prof. Antoniades at Oxford University, and has worked with the lab of Sarah-Jayne Blakemore (UCL) to produce works about the teenage brain.

    With support from Brain journal, Rebecca completed a public engagement art project (15 artworks) with Oxford neuro rehab academics and their stroke patients (click here for more). The project will go on show at the Centre for the Creative Brain at Oxford University in March 2020, details tbc.

    In addition to private collectors, Rebecca’s neuro works have been acquired by universities, dementia research and pharmaceutical companies in the UK, Europe and USA.